T40.99

Clinical Causes: Accidental ingestion of hallucinogenic substances, especially in unfamiliar or uncontrolled environments. Intentional misuse, such as recreational drug use for psychoactive effects. Underdosing or incorrect dosing, which may lead to unpredictable or adverse reactions. Use of contaminated or adulterated hallucinogenic substances. Combination of hallucinogens with other drugs or medications, increasing risk of adverse effects.

Key Symptoms: Hallucinations (visual, auditory, or tactile) Altered perception of time and space Mood changes, including euphoria or paranoia Impaired judgment and coordination Anxiety, panic attacks, or psychosis Nausea and vomiting Increased heart rate and blood pressure Dilated pupils Dizziness or loss of balance Serious reactions such as seizures or unconsciousness in extreme cases

Diagnosis Path: Diagnosis typically involves a comprehensive clinical assessment, including a detailed patient history related to substance use, physical examination, and sometimes laboratory tests. Laboratory analysis of blood, urine, or other biological samples may be conducted to identify the presence of hallucinogenic compounds or their metabolites. Healthcare providers also consider the pattern of symptoms and potential exposure history to confirm the diagnosis of poisoning or adverse effects related to psychodysleptics.

Treatment Protocols: Treatment approaches are primarily supportive and focus on managing symptoms. Immediate medical care might include intravenous fluids, medications to reverse specific symptoms (such as agitation or seizures), and monitoring vital signs. In severe cases, patients may require hospitalization for close observation and intervention. Psychological support and counseling can be beneficial for addressing underlying issues related to substance misuse. Importantly, ongoing research continues to explore specific antidotes or targeted therapies for hallucinogen poisoning, but current management remains largely supportive.